SESSION TITLE: Critical Care Posters III
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 28, 2015 at 01:30 PM - 02:30 PM
PURPOSE: Telepharmacy refers to utilizing telecommunications from a remote pharmacist to deliver care to patients unable to be in direct contact with the pharmacist. Pharmacy care includes patient counseling, drug therapy monitoring, prior authorization, refill authorization, and monitoring of formulary compliance. In our health care system comprised of three hospital campuses, all ICU teams desired that a Clinical Pharmacist participate in rounds each weekday. Although this is accomplished at the main campus ICU each weekday, the two satellite campus ICU teams are joined by a Clinical Pharmacist only one weekday a week. With this imbalance of Clinical Pharmacist input between the main and the satellite campuses, one satellite campus chose Telepharmacy to receive Clinical Pharmacist input on the four remaining weekdays. In this application of Telepharmacy, the remote Clinical Pharmacist rounds by phone with the ICU team. HYPOTHESIS Telepharmacy can provide useful interventions in the ICU.
METHODS: Two of our three hospital campuses were designated as control sites: the main campus: Clinical Pharmacist rounds each weekday, and satellite campus A: Clinical Pharmacist rounds only one weekday a week. The Telepharmacy intervention site was satellite campus B: Clinical Pharmacist rounds one weekday a week and Telepharmacy by a remote Clinical Pharmacist four weekdays a week. Conventional and Telepharmacy interventions for all campuses were compiled using two databases: Sentri7® Pharmacy Module (http://www.pharmacyonesource.com) and UHC Patient Safety Net® (https://psn.uhc.edu/patientsafety/FLR.mvc). Extracted and analyzed data included number of ICU patients, number of interventions, category of intervention, interventions per patient and interventions per patient per day.
RESULTS: Telepharmacy rounds were well accepted by both the Clinical Pharmacists and the ICU team but were considered time consuming by not occurring with standard ICU rounds.
CONCLUSIONS: 1. This application of Telepharmacy is able to maintain Clinical Pharmacist interaction with the ICU team each weekday. 2. Although Telepharmacy in this early stage is time consuming, future refinements in analyzing Sentri7® Pharmacy Module and UHC Patient Safety Net® entries should improve efficiencies of data extraction and clinical discussions.
CLINICAL IMPLICATIONS: Given common personnel and costs restraints for pharmacists in the present health care environment, Telepharmacy may provide an alternative to a Clinical Pharmacist being present in the ICU for daily rounds.
DISCLOSURE: The following authors have nothing to disclose: Herbert Patrick, Scott Lovenstein, Thomas Cole
The use of Telepharmacy, as described in this abstract, is a form of telemedicine. As we have applied Telepharmacy to improve patient quality and safety, our hospital has classified this project as QI/PI, and not research. However, we recognize that our submitted Telepharmacy technique "is not yet approved for any purpose."